Leslie Spry

844 total citations
24 papers, 265 citations indexed

About

Leslie Spry is a scholar working on Nephrology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Leslie Spry has authored 24 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 8 papers in Molecular Biology and 4 papers in Clinical Biochemistry. Recurrent topics in Leslie Spry's work include Dialysis and Renal Disease Management (8 papers), Metabolism and Genetic Disorders (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Leslie Spry is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Metabolism and Genetic Disorders (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Leslie Spry collaborates with scholars based in United States, Aruba and Canada. Leslie Spry's co-authors include Julio E. Benabe, Aubrey R. Morrison, Terry V. Zenser, Alison Steiber, Bernard B. Davis, Sachin Wani, Lorraine Weatherspoon, Alan T. Davis, Jennifer Strong and Joel D. Glickman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Endocrinology.

In The Last Decade

Leslie Spry

23 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leslie Spry United States	10	82	77	48	33	33	24	265
Javid Safa Iran	11	70 0.9×	53 0.7×	21 0.4×	50 1.5×	30 0.9×	26	336
Radana Gurecká Slovakia	8	81 1.0×	59 0.8×	59 1.2×	22 0.7×	81 2.5×	26	362
Bilge Aygen Türkiye	9	71 0.9×	60 0.8×	88 1.8×	10 0.3×	26 0.8×	16	360
Sharon Schilling Landgraf Brazil	9	113 1.4×	54 0.7×	20 0.4×	25 0.8×	32 1.0×	13	263
J.P. Charmes France	7	70 0.9×	47 0.6×	129 2.7×	20 0.6×	29 0.9×	13	330
Roberta Bordone Italy	9	104 1.3×	134 1.7×	20 0.4×	25 0.8×	27 0.8×	12	378
Leonardo Pazarín–Villaseñor Mexico	8	78 1.0×	133 1.7×	66 1.4×	15 0.5×	61 1.8×	20	335
U. C. Dubach Switzerland	12	82 1.0×	40 0.5×	35 0.7×	50 1.5×	30 0.9×	24	295
F. Scheler Germany	11	55 0.7×	66 0.9×	20 0.4×	18 0.5×	25 0.8×	37	353
Om P. Kalra India	12	113 1.4×	101 1.3×	22 0.5×	14 0.4×	24 0.7×	16	356

Countries citing papers authored by Leslie Spry

Since Specialization

Citations

This map shows the geographic impact of Leslie Spry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Spry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Spry more than expected).

Fields of papers citing papers by Leslie Spry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Spry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Spry. The network helps show where Leslie Spry may publish in the future.

Co-authorship network of co-authors of Leslie Spry

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Spry. A scholar is included among the top collaborators of Leslie Spry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Spry. Leslie Spry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dittrich, Mary, Jeffrey Silberzweig, Jeffrey L. Hymes, et al.. (2023). Management of Patients with Multidrug-Resistant Organisms in Outpatient Dialysis Facilities. Clinical Journal of the American Society of Nephrology. 19(5). 656–659.

Bu, Lihong, Samar M. Said, Loren Herrera Hernandez, et al.. (2023). The Characteristics of Concurrent Anti-Glomerular Basement Membrane Nephritis and Membranous Nephropathy. Kidney International Reports. 8(10). 2164–2167. 5 indexed citations

Silberzweig, Jeffrey, J. Ganesh Bhat, Mary Dittrich, et al.. (2022). Collaboration between Dialysis Providers. Journal of the American Society of Nephrology. 33(8). 1440–1444. 4 indexed citations

Lockridge, Robert S., Eric D. Weinhandl, Michael A. Kraus, et al.. (2020). A Systematic Approach To Promoting Home Hemodialysis during End Stage Kidney Disease. Kidney360. 1(9). 993–1001. 12 indexed citations

Spry, Leslie, et al.. (2015). Time savings of weekly versus three-times-per-week administration of erythropoiesis stimulating agents in United States dialysis patients. Current Medical Research and Opinion. 32(2). 313–320. 2 indexed citations

Steiber, Alison, et al.. (2011). Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation. Nephrology Dialysis Transplantation. 27(1). 304–310. 18 indexed citations

Spry, Leslie. (2008). Building the Chronic Kidney Disease Management Team. Advances in Chronic Kidney Disease. 15(1). 29–36. 4 indexed citations

Steiber, Alison, et al.. (2006). Carnitine Treatment Improved Quality‐of‐Life Measure in a Sample of Midwestern Hemodialysis Patients. Journal of Parenteral and Enteral Nutrition. 30(1). 10–15. 30 indexed citations

Steiber, Alison, Lorraine Weatherspoon, Leslie Spry, & Alan T. Davis. (2003). Serum carnitine concentrations correlated to clinical outcome parameters in chronic hemodialysis patients. Clinical Nutrition. 23(1). 27–34. 16 indexed citations

10.

Tomashek, Kay M., Leslie Spry, Diane M. Dwyer, et al.. (2000). Multistate outbreak of hemolysis in hemodialysis patients traced to faulty blood tubing sets. Kidney International. 57(4). 1668–1674. 18 indexed citations

11.

Spry, Leslie. (1999). Dialysis Clinic: The Diagnosis of Hemolysis During Hemodialysis. Seminars in Dialysis. 12(3). 205–205. 1 indexed citations

12.

Lakshmi, Vijaya M., Michael B. Mattammal, Leslie Spry, et al.. (1990). Metabolism and disposition of benzindine in the dog. Carcinogenesis. 11(1). 139–144. 16 indexed citations

13.

Spry, Leslie, et al.. (1988). Renal metabolic/excretory coupling. American Journal of Physiology-Renal Physiology. 254(1). F145–F152. 4 indexed citations

14.

Mattammal, Michael B., et al.. (1988). Renal metabolism of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide. Carcinogenesis. 9(11). 1975–1979. 1 indexed citations

15.

Rice, J R, et al.. (1988). Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.. PubMed. 48(2). 304–9. 9 indexed citations

16.

Spry, Leslie, Vijaya M. Lakshmi, Terry V. Zenser, & Beshaun J. Davis. (1986). Metabolism and excretion of nitrofurothiazole bladder carcinogens.. Journal of Pharmacology and Experimental Therapeutics. 238(2). 457–462. 5 indexed citations

17.

Spry, Leslie, Terry V. Zenser, Samuel M. Cohen, & Bernard B. Davis. (1985). Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.. Journal of Clinical Investigation. 76(3). 1025–1031. 14 indexed citations

18.

Spry, Leslie, et al.. (1985). Effect of phosphodiesterase inhibitors on bradykinin-mediated prostaglandin E2 and cyclic amp synthesis in renal papillary collecting tubule cells. Biochemical Pharmacology. 34(9). 1565–1569. 2 indexed citations

19.

Zenser, Terry V., N. S. Rapp, Leslie Spry, & Bernard B. Davis. (1984). Independent Effects of Bradykinin on Adenosine 3′,5′-Monophosphate and Prostaglandin E₂Metabolism by Rabbit Renal Medulla*. Endocrinology. 114(2). 541–544. 4 indexed citations

20.

Benabe, Julio E., Leslie Spry, & Aubrey R. Morrison. (1982). Effects of angiotensin II on phosphatidylinositol and polyphosphoinositide turnover in rat kidney. Mechanism of prostaglandin release.. Journal of Biological Chemistry. 257(13). 7430–7434. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact